List of patents in the Dry eye syndrome industry

Patent 7022117 was granted and assigned to Bausch & Lomb on April, 2006 by the United States Patent and Trademark Office.

Patent 8663639 was granted and assigned to Santen Pharmaceutical on March, 2014 by the United States Patent and Trademark Office.

Patent 11520166 was granted and assigned to Johnson & Johnson Vision Care on December, 2022 by the United States Patent and Trademark Office.

Patent 11878072 was granted and assigned to Alcon on January, 2024 by the United States Patent and Trademark Office.

Patent 8367097 was granted and assigned to Santen Pharmaceutical on February, 2013 by the United States Patent and Trademark Office.

Patent 9429514 was granted and assigned to Lumenis (company) on August, 2016 by the United States Patent and Trademark Office.

Patent 11555758 was granted and assigned to Bausch & Lomb on January, 2023 by the United States Patent and Trademark Office.

Patent 7400752 was granted and assigned to Alcon on July, 2008 by the United States Patent and Trademark Office.

Patent 11992437 was granted and assigned to Alcon on May, 2024 by the United States Patent and Trademark Office.

Patent 10524821 was granted and assigned to Lumenis (company) on January, 2020 by the United States Patent and Trademark Office.

Patent 10039565 was granted and assigned to Alcon on August, 2018 by the United States Patent and Trademark Office.

Patent 11701331 was granted and assigned to Aldeyra Therapeutics on July, 2023 by the United States Patent and Trademark Office.

Patent 11278395 was granted and assigned to Bausch & Lomb on March, 2022 by the United States Patent and Trademark Office.

Patent 11771664 was granted and assigned to Aldeyra Therapeutics on October, 2023 by the United States Patent and Trademark Office.

Patent 7368277 was granted and assigned to Otsuka Pharmaceutical on May, 2008 by the United States Patent and Trademark Office.

Patent 11559463 was granted and assigned to Otsuka Pharmaceutical on January, 2023 by the United States Patent and Trademark Office.

Patent 8016843 was granted and assigned to Alcon on September, 2011 by the United States Patent and Trademark Office.

Patent 7410799 was granted and assigned to Shire (pharmaceutical company) on August, 2008 by the United States Patent and Trademark Office.

Patent 12005033 was granted and assigned to Novaliq on June, 2024 by the United States Patent and Trademark Office.

Patent 7553101 was granted and assigned to Otsuka Pharmaceutical on June, 2009 by the United States Patent and Trademark Office.

Patent 11450144 was granted and assigned to Johnson & Johnson Vision Care on September, 2022 by the United States Patent and Trademark Office.

Patent 7422604 was granted and assigned to Bausch & Lomb on September, 2008 by the United States Patent and Trademark Office.

Patent 11311510 was granted and assigned to Johnson & Johnson Vision Care on April, 2022 by the United States Patent and Trademark Office.

Patent 10492862 was granted and assigned to Lumenis on December, 2019 by the United States Patent and Trademark Office.

Patent 9421092 was granted and assigned to Alcon on August, 2016 by the United States Patent and Trademark Office.